# LORIN (NCT05740943)

> Induction Lorlatinib in Stage III Non-small Cell Lung Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05740943
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Guangdong Provincial People's Hospital
- Conditions: Stage III NSCLC; Surgery
- Interventions: Lorlatinib
- Enrollment: 48
- Primary outcome: Pathological Complete Response (pCR)

## Indexed commentary on LORIN so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 32
- Podcasts: 3
- YouTube: 2
- Bluesky threads: 2

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=lorin-nct05740943

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT05740943", "email": "<work email>"}; the inbox owner confirms by the emailed link.